Lumida
/ARDX
⌘K
Ardelyx Inc

Ardelyx Inc

ARDX
$3.74USD-3.86%-0.15 today

MARKET CAP

932.0M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$4
$8

AI Summary

Stalk
TrimMedium

ARDX is in a pronounced Stage 4 downtrend, trading below all major EMAs with a clear lower-highs/lower-lows sequence. Medium-term bias is bearish, favoring selling rallies into the EMA9/20 resistance zone rather than initiating new positions at extreme lows. Short-term conditions remain unfavorable for selling into support near its 52-week low, so patience is warranted for bounce rejections around $4.06–4.21. Execution should focus on disciplined rejection at resistance levels.

  • Q2 2026 product revenue $118.1M (+31% YoY), IBSRELA $86.2M (+33% YoY).
  • Cash & equivalents of $281.8M support R&D and operations.
  • ROE of -39% highlights weak profitability and capital inefficiency.
Full analysis →

Buying

4

institutions

Selling

11

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY23.50 M119.87 M+2.34 M-5.4%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY16.74 M100.29 M+2.23 M+18.6%0.02%
MM

Millennium Management LLC

Q2 2026

SELL14.27 M72.79 M+-3.77 M-32.6%0.03%
AC

Aqr Capital Management LLC

Q2 2026

SELL2.32 M11.81 M+-123.23 K-19.2%0.00%
EP

Eversept Partners, LP

Q2 2026

SELL1.68 M8.56 M+-551.10 K-35.9%0.44%
CA

Citadel Advisors LLC

Q2 2026

SELL1.42 M7.24 M+-2.34 M-67.9%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL892.59 K4.55 M+-379.85 K-40.3%0.01%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

BUYNEW420.00 K2.14 M+420.00 K+0.0%0.49%
JC

Jpmorgan Chase & Co

Q2 2026

SELL225.80 K1.24 M+-204.34 K-48.2%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL76.60 K390.65 K+-123.62 K-67.4%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY57.70 K294.27 K+271.00-14.5%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL11.00 K56.10 K+-12.90 K-60.8%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

SELL0.000.00+-2.98 M-100.0%0.00%
MG

Man Group Plc

Q2 2026

SELL0.000.00+-79.60 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-74.10 K-100.0%0.00%